
Someone was watching over me, and I am grateful
Dave shares his 35 year survival story with testicular cancer. Diagnosed at 23, it was quite an ordeal for him all of those years ago.
Dave shares his 35 year survival story with testicular cancer. Diagnosed at 23, it was quite an ordeal for him all of those years ago.
As of December 2020, the Food and Drug Administration (FDA) has granted accelerated approval to Gavreto, the second drug for adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC). Gryt Health Chief Medical Officer, Dr. Dan breaks down the announcement.
A brief summary of out entire 2022 Mental Health Series from May. Included are the links to all of the individual summaries and 60 minute recorded sessions.
Nisa’s Non-Hodgkin’s Lymphoma “GRYT is” statement.
From March 2021, Gryt Health Chief Medical Officer, Dr. Dan, lays out what cancer patients need to know about COVID and vaccination.
Breast cancer survivor, Alexandra shares what GRYT is to her.
A press release from #GVCC21. See what you missed and see the link at the bottom to pre-register for #GVCC22!
In January 2021, Ben Comer from In Vivo chatted with Dave (Fuehrer) Craig about The COVID Advocacy Exchange, now known as The Advocacy Exchange. The Gryt Health initiative with BMS launched at the beginning of the COVID pandemic and is changing what patient advocacy looks like.
Challenging conversations about grief, death and dying with Jena Skelton, licensed counselor. This May 24th, 2022 session was powerful and empowering.
Program summary by Chris Chamars from September 2021. In this session, GRYT Health’s Chief Medical Officer, Dan Platt, MD, and Chief Research Officer, Darcy Flora, Ph.D., came together to talk about some of the most impactful projects we have done with our community. We dove into why it is important for you to not only learn about research but participate as an advocate because your voice has the potential to change the future of cancer care.